Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma

International Journal of Oncology

Volumn 38, Issue 1, 2011, Pages 133-143

  Motoda, Norio ^a   Matsuda, Yoko ^a   Onda, Munehiko ^a   Ishiwata, Toshiyuki ^a   Uchida, Eiji ^a   Naito, Zenya ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cell adhesion; Fibroblast growth factor 19 (FGF19); Fibroblast growth factor receptor 4 (FGFR4); Pancreatic ductal adenocarcinoma; Pancreatic intraepithelial neoplasia

Indexed keywords

ALPHA4 INTEGRIN; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR RECEPTOR 4; FIBRONECTIN; LAMININ; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PANCREATIC DUCTAL ADENOCARCINOMA; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; SIGNAL TRANSDUCTION; SURVIVAL RATE; UP-REGULATION;

EID: 78650820564     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000832     Document Type: Article

References (39)

1. Bardeesy N and DePinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909, 2002.
2. Matsuno S, Egawa S, Fukuyama S, et al: Pancreatic cancer registry in Japan: 20 years of experience. Pancreas 28: 219-230, 2004.
3. Klöppel G, Adler G, Hruban RH, Kern SE, Longnecker DS and Partanen TJ: Ductal adenocarcinoma of the pancreas. In: Tumours of the Digestive System. Vol 2. 3rd edition. Hamilton SR and Aaltonen LA (eds). International Agency for Research on Cancer, Lyon, pp221-230, 2000.
4. Feldmann G, Beaty R, Hruban R and Maitra A: Molecular genetics of pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Surg 14: 224-232, 2007.
5. Furukawa T: Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside. J Gastroenterol 43: 905-911, 2008.
6. Eswarakumar V, Lax I and Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149, 2005.
7. Xie M, Holcomb I, Deuel B, et al: FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11: 729-735, 1999.
8. Ornitz D, Xu J, Colvin J, et al: Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292-15297, 1996.
9. Ho H, Pok S, Streit S, et al: Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. J Hepatol 50: 118-127, 2009.
10. Roidl A, Berger H, Kumar S, Bange J, Knyazev P and Ullrich A: Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation. Clin Cancer Res 15: 2058-2066, 2009.
11. Takahashi A, Sasaki H, Kim S, et al: Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 257: 855-859, 1999.
12. Streit S, Mestel D, Schmidt M, Ullrich A and Berking C: FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients. Br J Cancer 94: 1879-1886, 2006.
13. Huang X, Yang C, Jin C, Luo Y, Wang F and McKeehan W: Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis. Mol Carcinog 48: 553-562, 2009.
14. Strack A and Myers R: Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)? Endocrinology 145: 2591-2593, 2004.
15. Song K, Li T, Owsley E, Strom S and Chiang J: Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 49: 297-305, 2009.
16. Goetz R, Beenken A, Ibrahimi O, et al: Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27: 3417-3428, 2007.
17. Wu X, Ge H, Lemon B, et al: Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Proc Natl Acad Sci USA 106: 14379-14384, 2009.
18. Pai R, Dunlap D, Qing J, Mohtashemi I, Hotzel K and French D: Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. Cancer Res 68: 5086-5095, 2008.
19. Desnoyers L, Pai R, Ferrando R, et al: Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene 27: 85-97, 2008.
20. Katoh M: Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059-1064, 2006.
21. Ishiwata T, Friess H, Büchler M, Lopez M and Korc M: Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 153: 213-222, 1998. (Pubitemid 28317524)
22. Kornmann M, Beger HG and Korc M: Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 17: 169-175, 1998.
23. Cho K, Ishiwata T, Uchida E, et al: Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol 170: 1964-1974, 2007.
24. Leung H, Gullick W and Lemoine N: Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 59: 667-675, 1994. (Pubitemid 24358591)
25. Partanen J, Mäkalä T, Eerola E, et al: FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 10: 1347-1354, 1991.
26. Weinstein M, Xu X, Ohyama K and Deng C: FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125: 3615-3623, 1998.
27. Hughes S: Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45: 1005-1019, 1997.
28. Bange J, Prechtl D, Cheburkin Y, et al: Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62: 840-847, 2002.
29. Wang J, Stockton D and Ittmann M: The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res 10: 6169-6178, 2004.
30. da Costa Andrade V, Parise H, Hors HP, de Melo Martins PC, Silva AP and Garicochea B: The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. Exp Mol Pathol 82: 53-57, 2007.
31. Matakidou A, El Galta R, Rudd M, et al: Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis. Br J Cancer 96: 1904-1907, 2007.
32. Shah R, Ibbitt J, Alitalo K and Hurst H: FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha. Oncogene 21: 8251-8261, 2002.
33. Wu X, Lemon B, Li X, et al: C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. J Biol Chem 283: 33304-33309, 2008.
34. Powers C, McLeskey S and Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7: 165-197, 2000.
35. Kummer C and Ginsberg M: New approaches to blockade of alpha4-integrins, proven therapeutic targets in chronic inflammation. Biochem Pharmacol 72: 1460-1468, 2006.
36. Walsh N, Clynes M, Crown J and O'Donovan N: Alterations in integrin expression modulates invasion of pancreatic cancer cells. J Exp Clin Cancer Res 28: 140, 2009.
37. Korc M: Pancreatic cancer-associated stroma production. Am J Surg 194: S84-S86, 2007.
38. Shaoul E, Reich-Slotky R, Berman B and Ron D: Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene 10: 1553-1561, 1995.
39. Raffioni S, Thomas D, Foehr E, Thompson L and Bradshaw R: Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells. Proc Natl Acad Sci USA 96: 7178-7183, 1999.